Antitumor activity of Cratylia mollis lectin encapsulated into liposomes

International Journal of Pharmaceutics

Volumn 278, Issue 2, 2004, Pages 435-445

  Andrade, Cesar A S ^a   Correia, Maria T S ^a   Coelho, Luana C B B ^a   Nascimento, Silene C ^a   Santos Magalhães, Nereide S ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Antitumor activity; Cratylia mollis; Cytotoxicity; Lectin; Liposomes

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME; PLANT LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; CRATYLIA MOLLIS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG STABILITY; ENCAPSULATION; HEMAGGLUTINATION; HISTOPATHOLOGY; KIDNEY; LIVER; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SARCOMA; SPLEEN; ULTRASOUND;

EID: 2942608184     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.03.028     Document Type: Article

References (24)

1. Amselen S., Gabizond A., Barenholz Y. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. Am. Pharm. Assoc. 79:1990;1045-1052
2. Barrat G.M. Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol. Today. 5:2000;163-171
3. Baszkin A., Boissonade M.M., Santos-Magalhães N.S., Carvalho L.B. Jr., Correia M.T.S., Coelho L.C.B.B. Cratylia mollis lectin at the air-aqueous solution interface: adsorption and lectin-lipid interactions. Colloids Surf. B: Biointerf. 17:2000;191-201
4. Beltrão E.I.C., Correia M.T.S., Silva J.F., Coelho L.C.C.B. Binding evaluation of isoform 1 from Cratylia mollis lectin to human mammary tissues. Appl. Biochem. Biotechnol. 74:1998;125-134
5. Bendas G., Vogel J., Bakowski U., Krause A., Müler J., Rhote U. A liposome-based model system for the simulation of lectin-induced cell adhesion. Biochim. Biophys. Acta. 1325:1997;297-308
6. Correia M.T.S., Coelho L.C.B.B. Purification of glucose-mannose specific lectin, isoform 1 from seeds of Cratylia mollis Mart. (Camaratu bean). Appl. Biochem. Biotechnol. 55:1995;261-273
7. Forssen E., Willis M. Ligand-targeted liposomes. Adv. Drug Deliv. Rev. 29:1998;249-271
8. Gabius H.J., Gabius S., Joshi S.S., Koch B., Schroeder M., Manzke W.M., Westerhausen M. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of Mistletoe? Planta Med. 60:1994;2-7
9. Geran, R.I., Greenberg, N.H., Macdonald, M.M., Schumacher, A.M., Abbott, B.J., 1972. Protocols for screening chemical agents and natural products against animal and other biological systems. In: Cancer Chemotherapy Reports, 3rd ed., vol. 3, Part III, p. 2.
10. Haas H., Falcone F.H., Schramm G., Haisch K., Gibbs B.F., Klaucke J., Pöppelmann M., Becker W.-M., Gabius H.-J., Schaak M. Dietary lectins can induce in vitro release of IL-4 and IL-13 from human basophils. Eur. J. Immunol. 29:1999;918-927
11. Hajto T., Hostanska K., Weber K., Zinke H., Fischer J., Mengs U., Lentzen H., Saller R. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo. Nat. Immun. 16:1998;34-46
12. Karasaki Y., Tsukamoto S., Mizusaki K., Sugiura T., Gotoh S. A Garlic lectin exerted an antitumor activity and induced apoptosis in human tumor cells. Food Res. Int. 34:2001;7-13
13. Kompella U.B., Lee V.H.L. Delivery systems for penetration enhancement of peptide and protein drugs: design considerations. Adv. Drug Deliv. Rev. 46:2001;211-245
14. Liener, I.E, Sharon, N., Goldstein, I.J. (Eds.), 1986.The Lectins: Properties, Functions and Applications on Biology Medicine. Academic press, Orlando, FL.
15. Mengs U., Weber K., Schwarz T., Hostanska K., Hajto T. Antimetastatic effect of a standardized Mistletoe preparation on B16 melanoma cells in mice. Eur. J. Cancer. 33:1997;S48
16. Meyer J., Whitcomb L., Collins D. Efficient encapsulation of proteins within liposomes for slow release in vivo. Biochem. Biophys. Res. Commun. 199:1994;433-438
17. Peterson G.L. A simplification of the protein assay method of Lowry, et al. which is more generally applicable. Anal. Biochem. 83:1977;36-356
18. Pontes A.C.O., Caetano M.N.P., Santos-Magalhães N.S. Physicochemical characterization and antimicrobial activity of Benzathine Penicillin G liposomes. STP Pharma Sci. 9:1999;419-427
19. Sadzuka Y., Hirota S., Sonobe T. Intraperitoneal administration of doxorubicin encapsulated liposomes against peritoneal dissemination. Toxicol. Lett. 116:2000;51-59
20. Timoshenko A.V., Lan Y., Gabius H.J., Lala P.K. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination: effects on tumor growth, capillary leakage and nitric oxide (NO) production. Eur. J. Cancer. 37:2001;1910-1920
21. Van Slooten M.L., Boerman O., Romoren K., Kedar E., Crommelin D.J.A., Storn G. Liposomes as sustained release system for human interferon-γ: biopharmaceutical aspects. Biochim. Biophys. Acta. 1530:2001;134-145
22. Wang H.X., Ng T.B., Liu W.K., Ooi V.E.C., Chang S.T. Isolation and characterization of two distinct lectins with antiproliferative activity from the cultured mycelia of the mushroom Tricholoma mongolicum. J. Peptide Protein Res. 46:1996;508-513
23. Wirth M., Hamilton G., Gabor F. Lectin-mediated drug targeting: quantification of binding and internalization of Wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. J. Drug Target. 6:1998;95-104
24. Yamazaki N., Kojima S., Bovin N.V., André S., Gabius S., Gabius H.-J. Endogenous lectins as targets for drug delivery. Adv. Drug Deliv. Rev. 43:2000;225-244